No Detail Found!

Comparative IgG antibody titers following second dose of Sinopharm and Pfizer vaccination

Author(s)
Hira Tanveer Department of Pharmacology, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore. National University of Medical Sciences, Islamabad, Pakistan.
Sehrish Zaffar Department of Pharmacology, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore. National University of Medical Sciences, Islamabad, Pakistan.
Muhammad Osama Department of Pharmacology, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore. National University of Medical Sciences, Islamabad, Pakistan.
Isma Ishaq Department of Pharmacology, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore. National University of Medical Sciences, Islamabad, Pakistan.
Javaria Arshad Malik Department of Pharmacology, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore. National University of Medical Sciences, Islamabad, Pakistan.
Rabiea Bilal Department of Pharmacology, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore, Pakistan; National University of Medical Sciences, Islamabad, Pakistan.
Afnan Talat Department of Pharmacology, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore. National University of Medical Sciences, Islamabad, Pakistan.
Aisha Talat Department of Pharmacology, Continental Medical College, Lahore, Pakistan.
Abstract
Background and Objective: The SARS-CoV-2 vaccines of Sinopharm and Pfizer have been reported to vaccinate more than 7.3 billion people across the globe. However, the protection oefred by these mRNA vaccines wanes with time, which is why the third dose of a diefrent or same vaccine may become necessary. The objective of this study was to compare the levels of immunoglobulin G (IgG) in the post-vaccination phase in the local population aeftr two doses with Sinopharm and Pfizer vaccination. Methods: A cross-sectional study was conducted at the Combined Military Hospital (CMH) Medical College and Institute of Dentistry, Lahore, Pakistan. A total of 100 adult participants who were completely vaccinated with either Sinopharm or Pfizer, at least 6 weeks before, were included in the study aeftr taking informed consent. Blood samples were collected and SARS-COV-2 virus IgG antibody levels were estimated using enzyme-linked immunosorbent assay (ELISA). The collected data were analyzed while taking a p value < 0.05 as significant. Results: The mean age of the participants was 20.18 ± 1.29 years. Mean antibody titers, six weeks post-vaccination were 5453.73 ± 609.15 units per milliliter (U/ml) and 10786.86 ± 1525.49 U/ml in Sinopharm and Pfizer groups, respectively. The diefrence was statistically significant (p = 0.0004). Conclusion: Antibody response was considerably higher in Pfizer-vaccinated individuals in comparison to Sinopharm in the local population from Pakistan.
Publication Details
Page(s) 178-182
Published Journal: Biomedica, Volume: 39, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Elisa, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, Pfizer, SinoPharm
0

Citations

0

Downloads

60

Views